Health
Oxford COVID-19 vaccine trials move to stage 3 human trials – News-Medical.Net
The technical name of the vaccine is ChAdOx1 nCoV-19 (AZD1222), as it is made from a virus called ChAdOx1, which is a weakened and non-replicating version of a common cold virus (adenovirus). The vaccine has been engineered to express the SARS-CoV-2 spike pro…

Scientists across the globe are racing to develop an effective and safe vaccine against severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2). The coronavirus pandemic has marked its …

Continue Reading
-
Business23 hours ago
This ASX dividend stock could be primed for a rebound
-
General24 hours ago
Unions call for stricter AI restrictions in workplaces
-
Noosa News24 hours ago
JCU hosts second Pride event – Proctor
-
Noosa News24 hours ago
Double-digit rainfall raises farmers’ hopes of bumper harvest in southern WA